Persistent macrolide resistance among group A streptococci: The lack of accomplishment after 4 decades. Editorial commentary

Clinical Infectious Diseases

Volumn 41, Issue 5, 2005, Pages 609-611

  Kaplan, Edward L ^a   Cornaglia, Giuseppe ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; ERYTHROMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; DRUG USE; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HUMAN; IN VITRO STUDY; NONHUMAN; NORTH AMERICA; NOTE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; UNITED STATES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MACROLIDES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 23844483484     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432480     Document Type: Note

References (16)

1. Sanders E, Foster MT, Scott D. Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin. N Engl J Med 1968; 278:538-40.
2. Richter SS, Heilmann KP, Beekmann SE, et al. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis 2005:41:599-608 (in this issue).
3. Tanz RR, Shulman ST, Shortridge VD, et al. Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. The North American Streptococcal Pharyngitis Surveillance Group. Clin Infect Dis 2004; 39:1794-801.
4. Erdem G, Ford J, Johnson D, Abe L, Yamaga K, Kaplan E. Erythromycin-resistant group A streptococcal isolates collected between 2000 and 2005 in Oahu, Hawaii, and their emm types. J Clin Microbiol 2005; 43:2497-9.
5. Bass JW, Weisse ME, Plymyer MR, Murphy S, Eberly BJ. Decline of erythromycin resistance of group A β-hemolytic streptococci in Japan: comparison with worldwide reports. Arch Pediatr Adolesc Med 1994; 148:67-71.
6. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337:441-6.
7. Huovinen P, Seppala H, Kataja J, Klaukka T. The relationship between erythromycin consumption and resistance in Finland. Finnish Study Group for Antimicrobial Resistance. Ciba Found Symp 1997; 207:36-41; discussion 41-6.
8. Hjaltested EK, Vilhelmsson SE, Kristinsson KG. Rapid increase of erythromycin-resistant Streptococcus pyogenes in Iceland [abstract 1217]. In: Programs and abstracts of the 39th International Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1999:156.
9. Granizo JJ, Aguilar L, Casal J, Dal-Re R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother 2000; 46:959-64.
10. Goossens H, Lammens C, Lontie M, et al. Streptococcus pyogenes resistance to erythromycin in relation to mechanism of resistance, genotype, and consumption of macrolides [abstract 1314]. In: Programs and abstracts of the 42nd International Conference on Antimicrobial Agents and Chemotherapy (San Diego). Washington, DC: American Society for Microbiology, 2001:134.
11. Bassetti M, Mantero E, Gatti G, Di Biagio A, Bassetti D. Streptococcus pyogenes erythromycin resistance in Italy. Emerg Infect Dis 1999; 5:302-3.
12. Cizman M, Pokorn M, Seme K, Paragi M, Orazem A. Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens. Eur J Clin Microbiol Infect Dis 1999; 18:522-4.
13. Cizman M, Pokorn M, Seme K, Orazem A, Paragi M. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J Antimicrob Chemother 2001; 47:475-7.
14. Austin DI, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc Natl Acad Sci USA 1999; 96:1152-6.
15. Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 2002; 346:1200-6.
16. Hsueh P-R, Shyr J-M, Wu J-J. Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan [letter]. Clin Infect Dis 2005;40:903-5.